Joseph C. Wu, MD, PhD is Director of Stanford Cardiovascular Institute and Simon H. Stertzer, MD, Professor of Medicine and Radiology at Stanford University. Dr. Wu received his MD from Yale University and PhD (Molecular & Medical Pharmacology) at University of California, Los Angeles. He is board certified in cardiovascular medicine. His lab works on cardiovascular genomics and induced pluripotent stem cells (iPSCs). The main goals are to (i) understand basic disease mechanisms, (ii) accelerate drug discovery via “clinical trial in a dish” concept, and (iii) implement precision medicine for patients. Dr. Wu has published >600 manuscripts with H-index of 137 on Google scholar. He is listed as top 0.1% of highly cited researchers by Web of Science for past 6 years (2018-2023). Dr. Wu has received several awards, including the NIH Director’s New Innovator Award, NIH Roadmap Transformative Award, Presidential Early Career Award for Scientists and Engineers (PECASE) given out by President Obama at the White House, American Heart Association (AHA) Distinguished Scientist Award, AHA Merit Award, and Burroughs Wellcome Foundation Innovation in Regulatory Science Award. Dr. Wu serves on the FDA Cellular, Tissue, and Gene Therapies Advisory Committee. He is on the Board of the Keystone Symposia and American Heart Association. He is the immediate past President of the American Heart Association (2023-2024). Dr. Wu is an elected member of American Society for Clinical Investigation (ASCI), Association of University Cardiologists (AUC), American Institute for Medical and Biological Engineering (AIMBE), American Association of Physicians (AAP), Academia Sinica (Taiwan), American Association for the Advancement of Science (AAAS), Asian American Academy of Science and Engineering (AAASE), National Academy of Inventors (NAI), and National Academy of Medicine (NAM). Joseph C. Wu, MD, PhD is Director of Stanford Cardiovascular Institute and Simon H. Stertzer, MD, Professor of Medicine and Radiology at Stanford University. Dr. Wu received his MD from Yale University and PhD (Molecular & Medical Pharmacology) at University of California, Los Angeles. He is board certified in cardiovascular medicine. His lab works on cardiovascular genomics and induced pluripotent stem cells (iPSCs). The main goals are to (i) understand basic disease mechanisms, (ii) accelerate drug discovery via “clinical trial in a dish” concept, and (iii) implement precision medicine for patients. Dr. Wu has published >600 manuscripts with H-index of 137 on Google scholar. He is listed as top 0.1% of highly cited researchers by Web of Science for past 6 years (2018-2023). Dr. Wu has received several awards, including the NIH Director’s New Innovator Award, NIH Roadmap Transformative Award, Presidential Early Career Award for Scientists and Engineers (PECASE) given out by President Obama at the White House, American Heart Association (AHA) Distinguished Scientist Award, AHA Merit Award, and Burroughs Wellcome Foundation Innovation in Regulatory Science Award. Dr. Wu serves on the FDA Cellular, Tissue, and Gene Therapies Advisory Committee. He is on the Board of the Keystone Symposia and American Heart Association. He is the immediate past President of the American Heart Association (2023-2024). Dr. Wu is an elected member of American Society for Clinical Investigation (ASCI), Association of University Cardiologists (AUC), American Institute for Medical and Biological Engineering (AIMBE), American Association of Physicians (AAP), Academia Sinica (Taiwan), American Association for the Advancement of Science (AAAS), Asian American Academy of Science and Engineering (AAASE), National Academy of Inventors (NAI), and National Academy of Medicine (NAM). Joseph C. Wu, MD, PhD is Director of Stanford Cardiovascular Institute and Simon H. Stertzer, MD, Professor of Medicine and Radiology at Stanford University. Dr. Wu received his MD from Yale University and PhD (Molecular & Medical Pharmacology) at University of California, Los Angeles. He is board certified in cardiovascular medicine. His lab works on cardiovascular genomics and induced pluripotent stem cells (iPSCs). The main goals are to (i) understand basic disease mechanisms, (ii) accelerate drug discovery via “clinical trial in a dish” concept, and (iii) implement precision medicine for patients. Dr. Wu has published >600 manuscripts with H-index of 137 on Google scholar. He is listed as top 0.1% of highly cited researchers by Web of Science for past 6 years (2018-2023). Dr. Wu has received several awards, including the NIH Director’s New Innovator Award, NIH Roadmap Transformative Award, Presidential Early Career Award for Scientists and Engineers (PECASE) given out by President Obama at the White House, American Heart Association (AHA) Distinguished Scientist Award, AHA Merit Award, and Burroughs Wellcome Foundation Innovation in Regulatory Science Award. Dr. Wu serves on the FDA Cellular, Tissue, and Gene Therapies Advisory Committee. He is on the Board of the Keystone Symposia and American Heart Association. He is the immediate past President of the American Heart Association (2023-2024). Dr. Wu is an elected member of American Society for Clinical Investigation (ASCI), Association of University Cardiologists (AUC), American Institute for Medical and Biological Engineering (AIMBE), American Association of Physicians (AAP), Academia Sinica (Taiwan), American Association for the Advancement of Science (AAAS), Asian American Academy of Science and Engineering (AAASE), National Academy of Inventors (NAI), and National Academy of Medicine (NAM).